Argutus Medical is the world leader in developing and manufacturing high quality, user-friendly, specialised organ injury tests. We primarily focus on developing ELISA and Rapid Tests for detection of acute injury to the kidney and liver. We also have a range of other assays and antibodies.
Argutus Medical was previously the Biomarkers division of Biotrin International before branching out in 2008. Since 2010 Argutus Medical has been part of the EKF Diagnostics Group plc which employs over 280 worldwide. This move has allowed Argutus Medical to focus more on biomarker development and on development of novel biomarker assays for these new biomarkers. Argutus Medical participates with a number of external key industry consortia including SAFE-T IMI and ILSI/HESI. These consortia aim to qualify pre-clinical and clinical biomarkers for regulatory approval.
Specialties
Biotechnology, Diagnostics, ELISA Manufacture
New hires at Argutus Medical
-
Business Development Assistant
Came from...
Sick Kids Hospital - Corporate Ventures Office, Volunteer
